What caused the FCG.AX stock volume spike today?

The spike to **1,184,838** shares likely reflects concentrated buying or short-covering in a thin market; absence of public major announcements suggests trade-driven interest. Verify order-book prints and ASX notices for contract or insider activity.

What are realistic near-term targets for FCG.AX stock?

Meyka AI models a **3-month target of A$0.05** and a **12-month projection of A$0.09** versus current **A$0.037**. These are model projections and not guarantees; monitor volume confirmation.

Is FCG.AX stock a buy after the volume spike?

A volume spike alone does not make FCG.AX stock a clear buy. Given small market cap, low liquidity and execution risk, consider disciplined entries with volume confirmation or wait for corporate catalysts such as earnings or contract wins.

How does Freedom Care Group compare to the healthcare sector?

FCG.AX stock trades at a low P/E (**4.50**) versus the ASX healthcare average P/E of **27.32**, indicating cheaper multiples. However, small scale and volatility mean sector multiples are imperfect comparators.

AU Stocks

FCG.AX Freedom Care Group (ASX) 10 Mar 2026: Volume jumps to 1.18M, monitor breakout

ByHuzaifa Zahoor March 10, 2026March 10, 2026

Intraday volume on FCG.AX stock surged to 1,184,838 shares on 10 Mar 2026, roughly 39.42 times the average volume, driving an intraday high of A$0.059 from an open at A$0.059 and a previous close of A$0.037. This spike signals a sudden liquidity shift in Freedom Care Group Holdings Ltd (FCG.AX) on the ASX and creates a short-term trading window. Traders should weigh the volume surge against thin market capitalisation of A$4.01M, low free float and the company’s exposure to NDIS funding. We assess fundamentals, technicals, Meyka AI grading and realistic price targets for intraday and near-term setups.